Monsanto (MON) EVP Sells $966,735.00 in Stock

Monsanto (NYSE:MON) EVP Steven Mizell sold 8,100 shares of the company’s stock in a transaction dated Tuesday, January 9th. The shares were sold at an average price of $119.35, for a total transaction of $966,735.00. Following the completion of the sale, the executive vice president now owns 56,743 shares in the company, valued at approximately $6,772,277.05. The sale was disclosed in a filing with the SEC, which is accessible through this link.

Monsanto (NYSE:MON) traded up $0.71 on Thursday, reaching $119.54. 2,864,151 shares of the company traded hands, compared to its average volume of 3,843,681. The firm has a market capitalization of $52,620.00, a price-to-earnings ratio of 22.10, a price-to-earnings-growth ratio of 1.69 and a beta of 1.04. Monsanto has a 52-week low of $106.74 and a 52-week high of $122.79. The company has a current ratio of 1.28, a quick ratio of 0.79 and a debt-to-equity ratio of 1.05.

Monsanto (NYSE:MON) last released its quarterly earnings data on Thursday, January 4th. The basic materials company reported $0.41 earnings per share for the quarter, missing the consensus estimate of $0.42 by ($0.01). The business had revenue of $2.66 billion for the quarter, compared to analyst estimates of $2.77 billion. Monsanto had a return on equity of 40.13% and a net margin of 16.38%. Monsanto’s revenue was up .3% compared to the same quarter last year. During the same quarter last year, the company earned $0.21 EPS. equities analysts anticipate that Monsanto will post 5.79 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, January 5th will be paid a dividend of $0.54 per share. The ex-dividend date of this dividend is Thursday, January 4th. This represents a $2.16 annualized dividend and a yield of 1.81%. Monsanto’s dividend payout ratio (DPR) is 39.93%.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in MON. Federated Investors Inc. PA raised its stake in Monsanto by 0.5% during the second quarter. Federated Investors Inc. PA now owns 9,555 shares of the basic materials company’s stock worth $1,131,000 after acquiring an additional 46 shares during the period. MUFG Securities EMEA plc acquired a new stake in Monsanto during the second quarter worth about $13,375,000. Key Square Capital Management LLC raised its stake in Monsanto by 4.1% during the second quarter. Key Square Capital Management LLC now owns 517,138 shares of the basic materials company’s stock worth $61,208,000 after acquiring an additional 20,209 shares during the period. Synovus Financial Corp raised its stake in Monsanto by 1.2% during the second quarter. Synovus Financial Corp now owns 7,211 shares of the basic materials company’s stock worth $854,000 after acquiring an additional 85 shares during the period. Finally, Northwestern Mutual Investment Management Company LLC grew its position in Monsanto by 320.1% in the 2nd quarter. Northwestern Mutual Investment Management Company LLC now owns 372,340 shares of the basic materials company’s stock worth $38,504,000 after purchasing an additional 283,703 shares during the last quarter. Hedge funds and other institutional investors own 75.34% of the company’s stock.

A number of brokerages have recently issued reports on MON. Barclays restated an “equal weight” rating and issued a $124.00 target price (up previously from $120.00) on shares of Monsanto in a research note on Thursday, October 5th. BMO Capital Markets restated a “buy” rating and issued a $128.00 target price on shares of Monsanto in a research note on Thursday, October 5th. Wells Fargo & Co upped their target price on shares of Monsanto from $107.50 to $118.00 and gave the company a “market perform” rating in a research note on Tuesday, October 10th. Macquarie lowered shares of Monsanto from an “outperform” rating to a “neutral” rating in a research note on Wednesday, October 4th. Finally, Zacks Investment Research upgraded shares of Monsanto from a “hold” rating to a “buy” rating and set a $132.00 target price on the stock in a research note on Thursday, September 14th. Eleven equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $126.40.

WARNING: “Monsanto (MON) EVP Sells $966,735.00 in Stock” was posted by American Banking News and is the property of of American Banking News. If you are reading this report on another domain, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The original version of this report can be viewed at https://www.americanbankingnews.com/2018/01/11/monsanto-mon-evp-sells-966735-00-in-stock.html.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Insider Buying and Selling by Quarter for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply